DR VANDERHEEREN PHILIPPE

Active

Private limited companyfounded 2020active for 6 yearsMarialoopsteenweg 47, 8760 Tielt, BelgiumKBO/BCE: BE 0743.620.410

From the official registers: KBO 6 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DR VANDERHEEREN PHILIPPE has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €351,682 and a net result of €107,027. Equity is growing by about 19% per year across the filed financial years. Its solvency ranks better than 49% of 20,659 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

DR VANDERHEEREN PHILIPPEActiveChecked score 94/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 13-02-2020 Normal situation
Legal form: Private limited company
Registered office: Marialoopsteenweg 47, 8760 Tielt
Activity: Specialist medical practice NACE 86220and 1 other
Establishment unit: 2.302.248.181 8760 Tielt, since 13-02-2020
Financial year end: 31 December
Peppol: Reachable since 16-12-2025

Company details

Who decides

Board

Vanderheeren PhilippeDirector · since 12-02-2020

Board & ownership

How it is doing

94 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Annual accounts 2025

Gross margin: €187,533; ▲ 15.1%
Turnover: ≈ €350,000; estimated
Profit: €107,027; ▲ 31.4%
Equity: €351,682; =
Total assets: €564,072; ▲ 3.4%

2025 accounts 31 days early

Filed on 30-06-2026at the National Bank

Financials

Why 94lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 2.97, cash €302,227Size: total assets €564,072Figures for financial year 2025 (filed 30-06-2026)Show the evidence

Checked score

Score 2025

94 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 53% of its sector peers (NACE 86, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 87-2

equity 62.3% of total assets

Liquidity 92-3

short-term debt 23.1% · cash 53.6%

Profitability 92+5

return on assets 19.0%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)

Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025lowest value 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026highest value 10-2026: < 0.1%● unchanged vs 09-2026

Credit of up to €30,000 on 30-day terms is acceptable

Liquidity ample (current ratio 2.97, compared with 3.94 in 2024, above the usual 1.5; short-term debt: 23.1% and cash: 53.6% of total assets), and 37.7% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 50% on solvency, 77% on liquidity, 50% on profitability and 37% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskneutral

Sector: Human health activities (NACE 86)

KBO

Liquidity: current ratio 2.97, cash €302,227

NBB · annual accounts

Size: total assets €564,072

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

Figures for financial year 2025 (filed 30-06-2026)

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.

NBB · 6 filings

Deviation from the deadline

2025

31 days early

2024

7 days early

2023

7 days early

2022

28 days late

2021

30 days late

2020

8 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 1 day after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 25 July (4 of the last 5 filed years within 34 days of that day).

Companies Code · seven months

Where today falls in the filing period

31-10-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

Key points

Positive: 6 profitable years in a rowprofit 2025: €107,027 6 years View

Documents

Key facts about DR VANDERHEEREN PHILIPPE

What is the company number of DR VANDERHEEREN PHILIPPE?: 0743.620.410. In Belgium the VAT number is the company number with BE in front: BE 0743.620.410.
Where is DR VANDERHEEREN PHILIPPE based?: The registered office is at Marialoopsteenweg 47, 8760 Tielt.Company details
What does DR VANDERHEEREN PHILIPPE do?: According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR VANDERHEEREN PHILIPPE?: Private limited company (BV).
When was DR VANDERHEEREN PHILIPPE founded?: On 13-02-2020.
Is DR VANDERHEEREN PHILIPPE still active?: Yes, DR VANDERHEEREN PHILIPPE is an active enterprise in the KBO register.
What is the turnover of DR VANDERHEEREN PHILIPPE?: ≈ €350,000 in financial year 2025. Estimated from the gross margin of €187,533: probably between €300,000 and €460,000, based on 43 comparable companies, NACE 86220.Financials
Is DR VANDERHEEREN PHILIPPE profitable?: In financial year 2025, DR VANDERHEEREN PHILIPPE made a profit of €107,027.
Where can I find the annual accounts of DR VANDERHEEREN PHILIPPE?: DR VANDERHEEREN PHILIPPE filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of DR VANDERHEEREN PHILIPPE due?: By 31-07-2027, for financial year 2026.Timeline